Molecular characterization of phenylketonuria patients from the North Region of Brazil: State of Pará

Mol Genet Genomic Med. 2023 Oct;11(10):e2224. doi: 10.1002/mgg3.2224. Epub 2023 Jul 8.

Abstract

Background: Phenylketonuria (PKU) is an autosomal recessive disease resulting from a deficiency of the enzyme phenylalanine hydroxylase (PAH). Hyperphenylalaninemias (HPA) due to PAH deficiency are accompanied by a wide variety of clinical, biochemical, and molecular features. To identify and characterize pathogenic variants in the PAH gene and establish a correlation between genotype and biochemical phenotype in patients with PKU from state of Pará in the North Region of Brazil.

Methods: All 13 exons of the PAH gene from 32 patients (21 PKU and 11 non-PKU HPA) were amplified by PCR and submitted to DNA sequencing (Sanger). Biochemical data were obtained from the patients' medical records.

Results: Molecular analysis identified 17 pathogenic variants and 3 nonpathogenic variants. The most frequent pathogenic variants were IVS10-11G>A (7.9%), p. Arg261Gln (7.9%), p. Val388Met (6.3%) and p. Ile65Thr (4.7%). Was observed correlations and inconsistencies between genotype and biochemical phenotype.

Conclusion: In PKU patients from state of Pará, North Region of Brazil, a heterogeneous mutation spectrum was revealed, in which the most frequent mutations are variants commonly observed in other Brazilian studies and in the region of the Iberian Peninsula.

Keywords: PKU; genotype-phenotype; north of Brazil; pathogenic variants; phenylketonuria.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brazil
  • Genotype
  • Humans
  • Mutation
  • Phenylalanine Hydroxylase* / genetics
  • Phenylketonurias* / genetics

Substances

  • Phenylalanine Hydroxylase